Roche Caps $2B Week With French Drug Co. Buy
Swiss biotech giant Roche Holding said Friday it will acquire a privately held French biotech developing a drug to treat spinal muscular atrophy for up to €470 million ($538.7 million), in...To view the full article, register now.
Already a subscriber? Click here to view full article